US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

120.88

-0.3600-0.30%

Post-market: 120.880.00000.00%19:30 EDT

Volume:21.60K

Turnover:2.61M

Market Cap:545.17M

PE:6.27

High:121.66

Open:121.66

Low:120.55

Close:121.24

52wk High:131.68

52wk Low:92.10

Shares:4.51M

Float Shares:4.51M

Volume Ratio:0.46

T/O Rate:0.48%

Dividend:1.11

Dividend Rate:0.92%

EPS(TTM):19.29

EPS(LYR):21.73

ROE:23.89%

ROA:0.60%

PB:1.64

PE(LYR):5.56

Loading ...

Overview Company News Filings

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease

Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease

THOMSON REUTERS

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity

THOMSON REUTERS

Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026

THOMSON REUTERS

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026

J&J DePuy Synthes to Showcase Next-Generation Trauma Devices at Orthopaedic Trauma Association Annual Meeting

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

DCC Energy Drops Planned Board Appointment After Takeover Approval

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS

Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PJP/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PJP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","market":"US","secType":"STK","nameCN":"INVESCO PHARMACEUTICALS ETF","latestPrice":120.88,"timestamp":1790971200000,"preClose":121.24,"halted":0,"volume":21601,"hourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.88,"latestTime":"19:30 EDT","volume":14,"amount":1692.28,"timestamp":1790983802888,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002969317057076868,"floatShares":4510000,"shares":4510000,"eps":19.286062,"marketStatus":"Market Closed","change":-0.36,"latestTime":"10-02 16:00:00 EDT","open":121.66,"high":121.66,"low":120.55,"amount":2612851.99177,"amplitude":0.009155,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":19.286062,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":121.24,"sharesOutstanding":3870000,"nav":121.31214,"aum":543994063.98,"dividendRate":0.009191,"bidAskSpread":0.000936,"preHourTrading":{"tag":"盘前","latestPrice":121.24,"preClose":121.24,"latestTime":"08:20 EDT","volume":3,"amount":363.71999999999997,"timestamp":1790943636164,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.88,"latestTime":"19:30 EDT","volume":14,"amount":1692.28,"timestamp":1790983802888,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4558769543236467,"impliedVol":0.0545,"impliedVolPercentile":0.1315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","floatShares":4510000,"roa":"0.60%","roe":"23.89%","lyrEps":21.734944,"volumeRatio":0.4558769543236467,"shares":4510000,"dividePrice":1.111031,"high":121.66,"amplitude":0.009155,"preClose":121.24,"low":120.55,"week52Low":92.095,"pbRate":"1.64","psRate":"107.56","week52High":131.675,"institutionHeld":0.824,"latestPrice":120.88,"eps":19.286062,"divideRate":0.009191,"volume":21601,"delay":0,"ttmEps":19.286062,"open":121.66,"prevYearClose":104.54,"prevWeekClose":126.82,"prevMonthClose":123.31,"prevQuarterClose":123.31,"fiveDayClose":126.82,"twentyDayClose":129.59,"sixtyDayClose":120.4458},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PJP\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PJP","amount":0.30136,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PJP","amount":0.27334,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PJP","amount":0.30902,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PJP","amount":0.24629,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PJP","amount":0.23633,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PJP\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.20736,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.03683,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.15586,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-29","value":0.12281,"currency":"USD"},{"executeDate":"2018-03-19","recordDate":"2018-03-20","paymentDate":"2018-03-29","value":0.05634,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PJP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PJP\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669147177","title":"Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147177?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:36","pubTimestamp":1790084178,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","BK4585","LU0289739699.SGD","BK4599","IE0002141913.USD","LU0109394709.USD","PJP","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BBH","BK4588","LU2112291526.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","BK4581","BIB","IE0009355771.USD","LU1057294990.SGD","LU0868494617.USD","PBE","TBXU","IBBQ","SG9999001440.SGD","LU0058720904.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","AMGN","BK4533","IBB","LU2089984988.USD","LU2242652126.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669472461","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669472461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669472461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lill...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN29S564.USD","LU0174119429.USD","LU1291159041.SGD","LU2896262040.SGD","IXJ","LU2023250504.SGD","LU2023251221.USD","BK4588","IE00BFSS7M15.SGD","LU2111349929.HKD","SG9999015986.USD","LU2237443549.SGD","LU1988902786.USD","GNOM","LU1548497426.USD","SGXZ81514606.USD","ELIL","LU1551013425.SGD","LU2461242641.AUD","LU1868836914.USD","LU2552382132.HKD","LU0787776722.HKD","BK4516","LU0096364046.USD","LU1868837136.USD","GDOC","LU2063271972.USD","IE0004445015.USD","SG9999013999.USD","LU0471298777.SGD","LU2271345857.HKD","LU2211815571.USD","LU0109391861.USD","LU0471298694.HKD","LU0820562030.AUD","LU2264538146.SGD","LU2265009873.SGD","LU0061475181.USD","LU1868836591.USD","LU2462157665.USD","IE00BK4W5L77.USD","LU2756315318.SGD","IDNA","IE0009355771.USD","LLII","LU0238689110.USD","LU1093756168.USD","SGXZ99366536.SGD","LU2471134796.USD","LU1323610961.USD","LU1061106388.HKD","LU0320765992.SGD","LU2237443382.USD","SG9999018865.SGD","LU1366192091.USD","IE00BKPKM429.USD","LU2089283258.USD","LU0354030438.USD","LU2324357040.USD","SG9999018857.SGD","LU2361044865.SGD","GB00BDT5M118.USD","MRNA","LU0225283273.USD","LU0203202063.USD","LU0210536198.USD","LU1035775433.USD","MRNY","LU1145028129.USD","SGXZ31699556.SGD","IE00B4R5TH58.HKD","BK4532","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU0106261372.USD","BK4139","LU0708995401.HKD","IE00B775H168.HKD","LU2236285917.USD","WDNA","LU0882574055.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2112291526.USD","LU2491050071.SGD","SG9999001176.SGD","SG9999014898.SGD","LU0345770993.USD","ELIS","HRTS","MRNX","LLY","LU0882574139.USD","MEDX","IE0001KFT4U8.USD","LU0114720955.EUR","LU1974910355.USD","BK4501","LU2602419157.SGD","BK4533","CANC","SG9999001176.USD","LU2471134523.USD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU0385154629.USD","LU2237443895.HKD","BK4581","LU0823434583.USD","FTXH","LU0158827948.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU1712237335.SGD","SGXZ57979304.SGD","RXL","LLYZ","SG9999015978.USD","LU2028103732.USD","LU0006306889.USD","LU0345770308.USD","IE00B2B36J28.USD","JDOC","LU2023250330.USD","LGHT","LU2168563687.JPY","LU2417539215.USD","LU2746668461.USD","PPH","LU1989771016.USD","MHIP","LU2468319806.SGD","BK4568","LU0456855351.SGD","LU2213496289.HKD","LU2361045086.USD","LU0234572021.USD","BK4551","BK4585","LLYX","ILDR","LU0466842654.USD","LU0079474960.USD","LU1623119135.USD","LU2456880835.USD","AGNG","LU1232071149.USD","LU2087625088.SGD","LU0316494557.USD","LU0353189680.USD","LU0786609619.USD","PJP","SG9999014914.USD","LU2168564222.USD","TRUH","LU0683600562.USD","CURE","LU0823416689.USD","FHLC","LU0266013472.USD","LU0640476718.USD","LU0964807845.USD","IE00BKDWB100.SGD","LU1720051108.HKD","IHE","IE0005OL40V9.USD","LU2089284900.SGD","LU1057294990.SGD","LU2360106947.USD","SG9999017495.SGD","IE00BWXC8680.SGD","LU0133085943.USD","SG9999014906.USD","BK4007","LU0320765059.SGD","LU0823434740.USD","LU2746668974.SGD","LU0943347566.SGD","LU1093756325.SGD","PYXS","LU2491049909.HKD","LU2361044949.HKD","LU2108987350.USD","LU0323591593.USD","LU0097036916.USD","LU0198837287.USD","LU0672654240.SGD","IE00BFSS8Q28.SGD","BK4599","LU1069344957.HKD","LU1804176565.USD","LU1868836757.USD","LU2168564495.EUR","LU1551013342.USD","LU2756315664.SGD","LU2168564065.EUR","TMED","LU0203201768.USD","LU0820561818.USD","LU0889565916.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","LU0820561909.HKD","LU2471134952.CNY","LU1691799644.USD","LU0109394709.USD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU0094547139.USD","LU1023059063.AUD","IE00B1XK9C88.USD","SG9999015952.SGD","IE00B4JS1V06.HKD","LU0122379950.USD","LU1983299246.USD","MEDI","LU2750360997.AUD","LU2552382215.SGD","LU1629891620.HKD","LU2106854487.HKD","SG9999014880.SGD","LU2471134879.HKD","LU2552382058.USD","LU0256863811.USD","IYH","LU2237443978.SGD","LU1917777945.USD","LU2750360641.GBP","LU0353189763.USD","LU2237443465.HKD","LU2237438978.USD","LU0417517546.SGD","LU2237443622.USD","LU1979441026.SGD","LU2491050154.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0058720904.USD","LU0432979614.USD","LU2357305700.SGD","LU2462591350.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","BK4534","OZEM","LU0256863902.USD","BK4548","LU2089984988.USD","THNR","SG9999015945.SGD","VHT","IE00BJJMRZ35.SGD","LU0158827781.USD","LU1280957306.USD","LU0689472784.USD","LU2168564149.EUR","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142751","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082402,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 22 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU0154236417.USD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","IE00BKVL7J92.USD","LU0097036916.USD","LU0708995401.HKD","LU2756315318.SGD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","NVOH","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","NVOC","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","NVOX","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","BK4532","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","NVO","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414223","title":"Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669414223?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082271,"startTime":"0","endTime":"0","summary":"Amgen says Phase 3 trial shows dazodalibep cuts systemic disease activity in Sjgren’s diseaseAmgen reported positive topline Phase 3 results for dazodalibep in adults with moderate-to-severe systemic ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL63L4Jz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","BK4581","TBXU","LU1983299246.USD","PJP","LU1023059063.AUD","LU2468319806.SGD","BK4534","LU2242652126.USD","LU0320765992.SGD","LU0868494617.USD","LU0058720904.USD","IBBQ","LU0289739699.SGD","IE00B2B36J28.USD","PBE","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1057294990.SGD","BK4139","BK4566","LU2242646821.SGD","SG9999001440.SGD","LU1571399168.USD","BK4585","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","IBB","LU2112291526.USD","BBH","IE00BJT1NW94.SGD","BK4599","BK4588","BK4533","LU2089984988.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142967","title":"Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142967?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082029,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","PJP","BBH","BIB","BK4534","LU2468319806.SGD","BK4581","LU1571399168.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","BK4566","LU2242652126.USD","LU2112291526.USD","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4588","IYH","RSPH","FHLC","BK4139","TRUH","BK4599","NVOX","PJP","BK4585","NVOC","CURE","NBDS","FXH","PINK","LENZ","BK4007","MEDI","NVOH","BK4539","VKTX","XLVI","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142945","title":"Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142945?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","PJP","BBH","BIB","BK4534","LU2468319806.SGD","BK4581","LU1571399168.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","BK4566","LU2242652126.USD","LU2112291526.USD","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142617","title":"Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142617?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","BK4534","IE00BJJMRZ35.SGD","BBH","PBE","LU0320765992.SGD","BK4599","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","BIB","LU1983299246.USD","BK4581","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","IBB","AMGN","IE00B2B36J28.USD","IBBQ","LU2112291526.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","LU2242652126.USD","LU1061106388.HKD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","LU0109394709.USD","LU1571399168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669445261","title":"Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669445261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669445261?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:22","pubTimestamp":1790079720,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now emerging competitors could soon challenge their lead.Seizing ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0787776722.HKD","SG9999018865.SGD","ILDR","BK4516","BK4599","ELIS","LU1983299246.USD","LU2237443622.USD","SGXZ81514606.USD","LU2462157665.USD","LU2168564149.EUR","LU2089284900.SGD","LU2168564065.EUR","03165","LU1623119135.USD","LU2023250330.USD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0256863902.USD","LU2750360641.GBP","SGXZ31699556.SGD","PJP","MEDX","LU0823416689.USD","LU0109391861.USD","IE00BKVL7J92.USD","SG9999017495.SGD","LU1712237335.SGD","RHHBY","LU0006306889.USD","GB00BDT5M118.USD","LU0174119429.USD","LU1291159041.SGD","SG9999013999.USD","LU0786609619.USD","LU2471134879.HKD","LU1232071149.USD","LU1868837300.USD","BK4532","NVOX","SG9999014906.USD","THNR","LU0354030511.USD","LU0154236417.USD","AGNG","IE00B775H168.HKD","LU2471134523.USD","LU2471134796.USD","LU2063271972.USD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014880.SGD","LU2324357040.USD","LU2746668461.USD","LU1551013425.SGD","LU0198837287.USD","LU0061475181.USD","IE00B4JS1V06.HKD","LU1366192091.USD","NVOH","IE00BK4W5M84.HKD","IE0004445015.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU1974910355.USD","LU0097036916.USD","LU2361045086.USD","LU2111349929.HKD","LU2211815571.USD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0203202063.USD","LU2089283258.USD","LU0683600562.USD","LU0820561909.HKD","LU0320765059.SGD","LU1323610961.USD","LU1093756325.SGD","SGXZ57979304.SGD","OZEM","LU2552382215.SGD","LU0820562030.AUD","HRTS","LLYX","LU1548497426.USD","LU0158827781.USD","LU0210536198.USD","LU0079474960.USD","LLII","LU0385154629.USD","IE00BJJMRY28.SGD","CURE","LU1551013342.USD","CANC","LU0466842654.USD","LU1061106388.HKD","LU2357305700.SGD","IHE","LU0417517546.SGD","LU2746668974.SGD","LU0234572021.USD","LU0456855351.SGD","SG9999014898.SGD","LU2360106947.USD","LU0889565916.HKD","LU1280957306.USD","LLY","LU1804176565.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","BK4534","LU1145028129.USD","LU0823434583.USD","LU1023059063.AUD","LU1868836757.USD","LU0289739699.SGD","LU0345770308.USD","LU0820561818.USD","LU1720051108.HKD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","LU2750360997.AUD","XLV","LU0225283273.USD","MEDI","TMED","IE00BFTCPJ56.SGD","LU0943347566.SGD","SG9999015945.SGD","LU2087625088.SGD","BK4588","IE00BK4W5L77.USD","LU0114720955.EUR","LU1035775433.USD","LU2756315664.SGD","LU1267930730.SGD","LU2552382058.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BZ1G4Q59.USD","IE00BJJMRX11.SGD","LU2471134952.CNY","LU0471298777.SGD","LU1868836591.USD","LU2236285917.USD","VHT","LU0094547139.USD","LU1691799644.USD","IE00B4R5TH58.HKD","LU0203201768.USD","LU0238689110.USD","BK4533","LU1917777945.USD","LU0256863811.USD","MHIP","LU2361044949.HKD","LU2237438978.USD","LU2462591350.SGD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LU2089984988.USD","LU2264538146.SGD","LU2491050154.USD","LU1069344957.HKD","JDOC","LU2602419157.SGD","LU2108987350.USD","SG9999001176.USD","LU2112291526.USD","LU1988902786.USD","BK4007","LU2237443382.USD","LU2271345857.HKD","BK4139","IE00BKPKM429.USD","SG9999015986.USD","IYH","FTXH","LU1629891620.HKD","LU2028103732.USD","LU0058720904.USD","LU2213496289.HKD","LU0158827948.USD","LU0640476718.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU1093756168.USD","LU2756315318.SGD","LU0323591593.USD","LU2168564222.USD","IE00BN29S564.USD","WDNA","FHLC","IE0002141913.USD","LU0882574139.USD","SG9999018857.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0354030438.USD","LU0672654240.SGD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","VKTX","LU0689472784.USD","IE00BWXC8680.SGD","LU0106261372.USD","IE0004445239.USD","LU0823434740.USD","SGXZ51526630.SGD","LU0964807845.USD","LU2468319806.SGD","LU2896262040.SGD","PPH","LU2491050071.SGD","LU0109394709.USD","LU0882574055.USD","NVO","LU2456880835.USD","TRUH","LU2237443549.SGD","LU0133085943.USD","NVOC","BK4585","IE00B1BXHZ80.USD","LU1057294990.SGD","IE00BJLML261.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2168563687.JPY","LU2237443978.SGD","LU2023251221.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU1064131342.USD","LU1868837136.USD","RXL","LU1979441026.SGD","LU0096364046.USD","LU0353189763.USD","LU0353189680.USD","SG9999001176.SGD","LU0345770993.USD","LU0320765992.SGD","LU0316494557.USD","LU0471298694.HKD","LU2361044865.SGD","BK4581","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669417501","title":"DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669417501","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669417501?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:09","pubTimestamp":1790078945,"startTime":"0","endTime":"0","summary":"DePuy Synthes showcases next-generation trauma innovations at OTA 2026Johnson & Johnson unit DePuy Synthes plans to showcase new trauma-care products at the OTA 2026 meeting in Nashville.Focus include","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8kzKlW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ80539844.SGD","IE00B42XCP33.USD","LU0210536198.USD","LU1914381329.SGD","LU0432979614.USD","LU0124676726.USD","BK4007","IE0001KFT4U8.USD","IE00BLSP4239.USD","SG9999002232.USD","LU2471134523.USD","SG9999013999.USD","VHT","BMED","LU0114720955.EUR","LU0289961442.SGD","IYH","LU1732800096.USD","LU0683600562.USD","LU1162221912.USD","LU1430594728.SGD","RXL","TRUH","JDOC","MEDX","IE0002141913.USD","LU2430703251.USD","LU0053666078.USD","LU0820562030.AUD","LU0912757837.SGD","LU1244550221.USD","JNJ","LU1894683264.USD","XLV","IE00B3PB1722.GBP","LU1674673428.USD","IE00BVYPNV92.GBP","IE00BKVL7J92.USD","LU2471134879.HKD","LU0289739699.SGD","IHE","LU0098860793.USD","IE00BBT3K403.USD","PJP","IXJ","FTXH","GDOC","FHLC","LU0795875086.SGD","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141166","title":"J&J DePuy Synthes to Showcase Next-Generation Trauma Devices at Orthopaedic Trauma Association Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141166","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141166?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:01","pubTimestamp":1790078464,"startTime":"0","endTime":"0","summary":"J&J DePuy Synthes to showcase next-generation trauma devices at Orthopaedic Trauma Association annual meetingJohnson & Johnson’s DePuy Synthes will showcase trauma devices at the 2026 Orthopaedic Trau","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1W4nks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1043141123.HKD","IE00BN8TJ469.HKD","LU1732800096.USD","VHT","LU1196500208.SGD","IYH","LU1003077747.HKD","LU0882574055.USD","LU2756315318.SGD","JNJ","RXL","LU0432979614.USD","LU0985320562.USD","LU1032955483.USD","TRUH","BK4568","FHLC","LU0943347566.SGD","LU0949170772.SGD","LU1894683264.USD","IE00BLSP4452.SGD","LU0053666078.USD","GDOC","LU0122379950.USD","LU1629891620.HKD","MEDX","BMED","IE00B19Z3B42.SGD","LU1280957306.USD","FTXH","LU1430594728.SGD","LU0792757196.USD","PJP","XLV","JDOC","IE0034235303.USD","LU0210528500.USD","IHE","LU0345770993.USD","IXJ","LU0057025933.USD","LU0162691827.USD","LU1066053197.SGD","LU0203345920.USD","IE00BLSP4239.USD","LU1162221912.USD","IE000F7OJYX1.SGD","IE000M9KFDE8.USD","LU0889566641.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD","BK4139","IE00B2B36J28.USD","BK4585","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4599","LU1983299246.USD","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU0029874061.USD","BK4533","HCSG","LU1023059063.AUD","LABU","BK4539","IVVD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0122379950.USD","LU1571399168.USD","BK4137","BK4566","IBBQ","LU0128526141.USD","IE0009355771.USD","LU0289739699.SGD","BK4563","XLV","XBI","LU0889565916.HKD","PBE","LU2242652126.USD","IE00BJJMRZ35.SGD","BBH","HUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914330","title":"AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914330","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669914330?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:55","pubTimestamp":1790070911,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the European Commission has approved Rinvoq for the treatment of active polyarticular juvenile idiopathic arthritis in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B42XCP33.USD","LU1934455277.USD","MEDX","ABBV","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1670628061.USD","FTXH","AGNG","PPH","IXJ","JDOC","SG9999015945.SGD","GLAM","LU0234570918.USD","LU0738911758.USD","TRUH","LU0203347892.USD","IE00BVYPNW00.USD","LU2089284900.SGD","IE0004445239.USD","VHT","LU0943347566.SGD","IYH","LU2357627491.SGD","LU2089984988.USD","LU1923622614.USD","LU0708994859.HKD","LU0289739343.SGD","FHLC","LU0432979614.USD","LU0456855351.SGD","LU1093756168.USD","PJP","LU1718418525.SGD","LU2129689514.USD","RXL","LU0198837287.USD","XLV","LU1732799900.SGD","LU0861579265.USD","SG9999015986.USD","LU0256863902.USD","LU1732800096.USD","IE0009355771.USD","EPV","IE00BLSP4239.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU0395794307.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143863","title":"DCC Energy Drops Planned Board Appointment After Takeover Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143863?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:47","pubTimestamp":1790070446,"startTime":"0","endTime":"0","summary":"DCC plc ( ($GB:DCC) ) has provided an update. DCC Energy plc has confirmed that John Abbott will no longer join its board as an independent non-exe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dcc-energy-drops-planned-board-appointment-after-takeover-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dcc-energy-drops-planned-board-appointment-after-takeover-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4585","LU0266013472.USD","ABT","LU0289739699.SGD","LU0070302665.USD","LU1670628061.USD","LU1691799644.USD","LU1989763427.SGD","LU1670627923.USD","PJP","LU1989763690.USD","IE00B2B36J28.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0170899867.USD","LU0211331839.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1983299246.USD","LU2237957811.SGD","LU2468319806.SGD","BK4588","SG9999004303.SGD","TMED","LU1061106388.HKD","LU2211815571.USD","BK4581","IE0009355771.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999002232.USD","LU0058720904.USD","LU2237957902.USD","BK4592","LU0234572021.USD","BK4568","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0882574055.USD","LU1721429402.USD","SGXZ41872573.SGD","BK4533","LU2089984988.USD","LU2133065610.SGD","IHI","LU0114720955.EUR","LU1721429741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669511784","title":"Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669511784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669511784?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:32","pubTimestamp":1790065920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.84 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25087.75.Sino Biopharmaceutical Ltd. closed 32% short of its 52-week high of HK$8.56, which the company reached Sept. 23.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.1% and Amgen Inc. remained unchanged.Trading volume totaled 87.2 million shares, compared to the 50-day average of 88.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","PBE","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BK1589","BIB","IE00BZ08YR35.GBP","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","BK1515","IE00BZ08YS42.EUR","IE00BJJMRZ35.SGD","BK4581","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","IE00BZ08YT58.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","HK0000165453.HKD","LU2242652126.USD","BK1521","IBBQ","LU0868494617.USD","IE00BJT1NW94.SGD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119912","title":"AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119912","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119912?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:41","pubTimestamp":1790059265,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Announces European Commission Approval Of RINVOQ (Upadacitinib)Sept 22 (Reuters)-AbbVie Inc.ABBV.N:ABBVIE ANNOUNCES EUROPEAN COMMISSION APPROVAL OF RINVOQ (UPADACITINIB) FOR THE TREATMENT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620834.HKD","LU1720051108.HKD","ABBV","GLAM","IE00B2B36J28.USD","LU1989772840.SGD","IXJ","LU1093756168.USD","TRUH","LU0114720955.EUR","LU1548497426.USD","LU2357627491.SGD","LU0211328371.USD","IE00BLSP4452.SGD","VHT","IE0002270589.USD","LU1732799900.SGD","LU0943347566.SGD","LU1989771016.USD","BK4550","LU0057025933.USD","LU0795875086.SGD","LU2112291526.USD","MEDX","RXL","SG9999015986.USD","XLV","BK4588","LU2023251221.USD","FHLC","LU0069063385.USD","LU0203347892.USD","LU0689626769.HKD","IYH","LU0029864427.USD","IE00BGHQF631.EUR","LU2129689514.USD","PJP","FTXH","LU1934455194.USD","IE00BN8TJ469.HKD","AGNG","IE000MB6IJN5.SGD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU0256863902.USD","LU0985320562.USD","PPH","JDOC","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116311","title":"AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116311","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116311?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:01","pubTimestamp":1790056875,"startTime":"0","endTime":"0","summary":"AbbVie says EU approves Rinvoq for children with polyarticular juvenile idiopathic arthritisEuropean Commission cleared AbbVie’s Rinvoq for active polyarticular juvenile idiopathic arthritis in patien","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1SztCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","IE00BSNM7G36.USD","LU0320765646.SGD","JDOC","LU0965508806.USD","LU1732799900.SGD","LU2125909593.SGD","LU2347655156.SGD","LU2112291526.USD","ABBV","BK4588","IXJ","LU0820561909.HKD","LU1989771016.USD","SG9999015986.USD","LU0823416689.USD","LU0965509283.SGD","LU2357627491.SGD","VHT","XLV","FHLC","IE00BJT1NW94.SGD","LU1236620750.USD","LU0912757837.SGD","LU1983299246.USD","LU0057025933.USD","MEDX","PJP","LU0868494617.USD","FTXH","LU0472753341.HKD","IE000SO60NU8.SGD","BK4550","IE00BVYPNV92.GBP","LU0882574055.USD","BK4533","TRUH","IE00BVYPNW00.USD","LU0058720904.USD","LU0256863811.USD","LU0985320562.USD","LU0432979614.USD","RXL","AGNG","LU1989772840.SGD","PPH","GLAM","IYH","LU1934455277.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669844116","title":"Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669844116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669844116?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:00","pubTimestamp":1790056801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000BZT7R73.USD","FTXH","IYH","LU0661504455.SGD","LU1551013425.SGD","LU1720051108.HKD","XLV","IE00BGHQF631.EUR","LU0057025933.USD","IE00BFTCPJ56.SGD","LU0943347566.SGD","GLAM","LU0114720955.EUR","LU1934455863.HKD","SG9999011175.SGD","LU1162221912.USD","FHLC","IE0002141913.USD","LU2089283258.USD","LU0124676726.USD","IXJ","LU1989771016.USD","LU0689472784.USD","LU0128525929.USD","LU1923622614.USD","MEDX","PJP","VHT","LU0211327993.USD","LU2468319806.SGD","PPH","LU0965509101.SGD","LU0859254822.USD","TRUH","LU1934455194.USD","LU1267930573.SGD","LU2237443549.SGD","IE000MB6IJN5.SGD","LU1718418525.SGD","LU0456855351.SGD","LU1496350171.SGD","LU0708994859.HKD","JDOC","RXL","AGNG","LU0069063385.USD","LU0965508806.USD","LU1023059063.AUD","BK4581","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116885","title":"Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116885?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:00","pubTimestamp":1790056801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","AGNG","LU0170899867.USD","RXL","LU0124676726.USD","LU1934455277.USD","PPH","JDOC","FHLC","LU0256863902.USD","FTXH","LU1551013425.SGD","LU1934455194.USD","LU2125909593.SGD","LU1670628061.USD","PJP","LU1732800096.USD","LU0965508806.USD","BK4581","IYH","IE00B3PB1722.GBP","LU0511384066.AUD","LU0395794307.EUR","IE00BN8TJ469.HKD","LU0432979614.USD","LU2089984988.USD","LU0114720955.EUR","GLAM","LU1074936037.SGD","XLV","LU0965509101.SGD","LU1839511570.USD","LU0234572021.USD","VHT","BK4534","LU1670627923.USD","LU2357627491.SGD","LU0320765646.SGD","LU1023059063.AUD","BK4533","LU0158827948.USD","LU1244550577.SGD","TRUH","LU0545039389.USD","SG9999001440.SGD","LU1057294990.SGD","LU1267930573.SGD","ABBV","IXJ","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619560","title":"Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619560","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619560?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:55","pubTimestamp":1790027717,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company  said Monday it has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, that will produce its oral GLP-1 drug Foundayo along with other small-molecule medicines and advanced therapeutics.Lilly said the facility is expected to create more than 600 high-wage jobs and roughly 4,000 construction jobs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0672654240.SGD","LU2491049909.HKD","LU2602419157.SGD","IHE","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1035775433.USD","LU0320765059.SGD","LU0823434740.USD","BK4534","LU2237438978.USD","LU2111349929.HKD","LU1291159041.SGD","LU0058720904.USD","IXJ","WDNA","LU2023250504.SGD","LU2168564065.EUR","LU1868836914.USD","PPH","XLV","BK4581","CANC","LU2023250330.USD","MEDI","SG9999015986.USD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU1069344957.HKD","LU0456855351.SGD","LU1988902786.USD","LU0266013472.USD","LU0820561909.HKD","SG9999015978.USD","BK4599","LU1804176565.USD","ILDR","IE0004445015.USD","LU1983299246.USD","ELIS","LU0689472784.USD","LU2471134879.HKD","LU2063271972.USD","LU0323591593.USD","LU2462591350.SGD","LU0345770308.USD","LU2491050071.SGD","LU2750360641.GBP","SGXZ31699556.SGD","TMED","FTXH","LU1232071149.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0683600562.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU0114720955.EUR","LU1127390331.HKD","LU0354030438.USD","LU0133085943.USD","LU2361045086.USD","LU2756315664.SGD","SG9999015952.SGD","LU0882574055.USD","LU0354030511.USD","LU0320765992.SGD","LU0096364046.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU2106854487.HKD","LU0417517546.SGD","BK4588","LU0708995401.HKD","LU0823434583.USD","IE0002141913.USD","LU0943347566.SGD","LU1551013425.SGD","LU2108987350.USD","CURE","GDOC","LU2361044865.SGD","LU1061106388.HKD","LU1868837300.USD","LU2237443549.SGD","BK4516","IE00B4JS1V06.HKD","LU1720051017.SGD","LU0174119429.USD","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","IE00BKPKM429.USD","IE00BN29S564.USD","LU2471134523.USD","LU2168563687.JPY","LU2023251221.USD","LU2491050154.USD","LU0109391861.USD","LU2271345857.HKD","LU2264538146.SGD","SG9999018857.SGD","LLYZ","IE00B1BXHZ80.USD","LU0094547139.USD","LU0964807845.USD","SG9999001176.SGD","IE0005OL40V9.USD","LU1093756325.SGD","BK4007","LU2168564495.EUR","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU1093756168.USD","LU2417539215.USD","LU1917777945.USD","LU2168564222.USD","LU0079474960.USD","LU0256863902.USD","LU2089284900.SGD","IE00B775H168.HKD","LU0225283273.USD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","IE00BJJMRX11.SGD","IE00BK4W5L77.USD","AGNG","LU1551013342.USD","LU2471134796.USD","LU2357305700.SGD","LU2896262040.SGD","HRTS","LU2324357040.USD","LU2461242641.AUD","LU2265009873.SGD","IE0004445239.USD","LU1023059063.AUD","SG9999014906.USD","LU2746668461.USD","LU1145028129.USD","LU2237443465.HKD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1548497426.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0109394709.USD","LU1623119135.USD","LU0316494557.USD","LU0203202063.USD","LU2236285917.USD","RXL","LU0345770993.USD","FHLC","LLYX","LU0353189763.USD","LU2168564149.EUR","LU0234572021.USD","LU2361044949.HKD","LU2237443978.SGD","SG9999018865.SGD","SGXZ81514606.USD","SG9999017495.SGD","LU0385154629.USD","LU2087625088.SGD","LU1280957306.USD","LU2746668974.SGD","LU2756315318.SGD","VHT","LU1366192091.USD","THNR","LU0097036916.USD","IE00BKDWB100.SGD","LU0061475181.USD","LU0882574139.USD","LU1868836757.USD","LU2211815571.USD","LU2750360997.AUD","SG9999014914.USD","LU1868836591.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU0466842654.USD","MEDX","LU0786609619.USD","LU1267930730.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","LU0289739699.SGD","LU2471134952.CNY","LU0353189680.USD","LU2552382058.USD","ELIL","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","LU0158827948.USD","LU0203201768.USD","LU0106261372.USD","LU1057294990.SGD","TRUH","LU0820561818.USD","LU1868837136.USD","LU0823416689.USD","LU2360106947.USD","LU2552382132.HKD","SGXZ99366536.SGD","LU2089283258.USD","LU1629891620.HKD","SG9999015945.SGD","IYH","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","LU1323610961.USD","LU1064131342.USD","BK4533","LU0158827781.USD","LU0210536198.USD","LU1720051108.HKD","LU1979441026.SGD","LU1989771016.USD","LU2456880835.USD","LU0471298777.SGD","LLII","LU0471298694.HKD","LLY","LU1814569148.SGD","LU2552382215.SGD","LU0787776722.HKD","MHIP","OZEM","LU2213496289.HKD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":13,"totalSize":293,"code":"91000000","status":"200"}]}}